Subscribe to this collection to receive daily e-mail notification of new additions

	Title	Author(s)	Issue Date
	Antiviral activity, pharmacokinetics and safety of the second-generation hepatitis B core inhibitor ABI-H2158 in Phase 1b study of patients with HBeAg-positive chronic hepatitis B infection Proceeding/Conference:Journal of Hepatology	Agarwal, KNiu, JDing, YGane, ENguyen, TAlves, KEvanchick, MZayed, HHuang, QKnox, SStamm, LColonno, RHassanein, TKim, DJLim, YSYuen, RMF	2020
	Suboptimal linkage to care after identification of serum hepatitis B surface antigen-positive individuals in territory-wide screening: a need for educational and public health policies Proceeding/Conference:Journal of Hepatology	Ko, KLLiu, SHKFung, JYYMak, LYYuen, RMFSeto, WKW	2020
	Antiviral activity and safety of the hepatitis B core inhibitor ABI-H0731 administered with a nucleos(t)ide reverse transcriptase inhibitor in patients with HBeAg-negative chronic hepatitis B infection Proceeding/Conference:Journal of Hepatology	Fung, SSulkowski, MLalezari, JSchiff, ERDieterich, DHassanein, TKwo, PElkhashab, MNahass, RAyoub, WHan, SHBonacini, MAlves, KZayed, HHuang, QColonno, RKnox, SRamji, ABennett, MGane, ERavendhran, NPark, JJacobson, IBae, HChan, SHann, HWMa, XNguyen, TYuen, RMF	2020
	Preliminary safety and antiviral activity of VIR-2218, an X-targeting HBV RNAi therapeutic, in chronic hepatitis B patients Proceeding/Conference:Journal of Hepatology	Gane, ELim, YSTangkijvanich, PO'Beirne, JLim, THBakardjiev, ADing, XConnolly, LHuang, SKim, JPang, PYuen, RMF	2020
	Hepatitis B virus (HBV) surface antigen (HBsAg) inhibition with isis 505358 in chronic hepatitis B (CHB) patients on stable nucleos(t)ide analogue (NA)-naïve CHB patients: phase 2a, randomized, double-blind, placebo-controlled study. Proceeding/Conference:Journal of Hepatology	Yuen, RMFHeo, JJang, JWYoon, J-HKweon, YOPark, S-JBennett, FKwoh, J	2020
	Phase 2a, randomized, double-blind, placebo-controlled study of an antisense inhibitor (ISIS 505358) in treatment-naïve chronic hepatitis B (CHB) patients: safety and antiviral efficacy Proceeding/Conference:Hepatology	Yuen, RMFHeo, JJang, JWYoon, JHKweon, YOPark, SJBennett, CFKwoh, TJ	2019
	MORTALITY, REVASCULARIZATION AND CARDIOPROTECTIVE PHARMACOTHERAPY AFTER ACUTE CORONARY SYNDROME IN PATIENTS WITH PSYCHOTIC DISORDERS: A POPULATION-BASED COHORT STUDY Proceeding/Conference:Schizophrenia International Research Society (SIRS) Annual Congress 2020	Chang, WCChan, KNWong, SMCOr, PCFHai, SHJJ	2020
	Plasma adipocyte fatty acid=binding protein and adiponectin levels are associated with fibrosis regression in nucleoside analogue-treated chronic hepatitis B: a prospective study with paired transient elastography Proceeding/Conference:Journal of Hepatology	Hui, WHRMak, LYFung, JYYWong, DKHYuen, RMFSeto, WKW	2020
	Results after 12 weeks treatment of multiple doses of GSK3389404 in chronic hepatitis B (CHB) subjects on stable nucleos(t)ide therapy in a phase 2a double-blind, placebo-controlled study Proceeding/Conference:Hepatology	Yuen, RMFHeo, JKumada, HSuzuki, FSuzuki, YXie, QJia, JDKarino, YHou, JLChayama, KImamura, Mlao-Tan, JYLim, SGTanaka, YXie, WYoon, JHDuan, ZPKurosaki, MPark, SJLabio, EKumar, RKweon, YOYim, HJCremer, JElston, RChen, SGDavies, MBaptiste-Brown, SHan, KCampbell, FPaff, MTheodore, D	2019
	Low HBcrAg and HBsAg levels identify patients most likely to achieve sustained response after nucleos(t)ide analogue cessation: results from a global individual patient data meta-analysis (create study) Proceeding/Conference:Journal of Hepatology	Sonneveld, MPark, JYSeto, WKWTanaka, YCarey, IPapatheodoridi, MZoulim, FAhn, SHDalekos, GHoener zu Siederdissen, CCornberg, MYuen, RMFAgarwal, KBoonstra, AButi, MPapatheodoridis, GMaasoumy, B	2020
	Resistance monitoring data from treatment-naïve chronic HBV infected patients treated for 28 days with a new class a core protein allosteric modulator RO7049389 monotherapy Proceeding/Conference:Journal of Hepatology	Zhou, XKazma, RMeinel, DZhou, YYuen, RMFGane, ESchwabe, CTanwandee, TCao, LZhou, JBo, Q	2020
	And end-to-end artificial intelligence model accurately diagnosing hepatocellular carcinoma on computed tomography Proceeding/Conference:United European Gastroenterology Journal	Seto, WKWChiu, WHKYu, PLHCao, WCheng, HMWong, EMFWu, JLui, GCSShen, XMak, LYLi, WKYuen, RMF	2020
	Gut Microbiome-derived Lipopolysaccharide Contributes to Pathogenesis of Murine Lupus Nephritis Proceeding/Conference:Nephrology	Yu, JChan, CYCTai, ACPYung, SSYChan, DTM	2020
	A genome-wide association study for sight-threatening diabetic retinopathy in Chinese patients with type 2 diabetes - an Asian Screening Array analysis Proceeding/Conference:Diabetologia	Cheung, YYLee, CHPNg, KKKXu, AFong, CHYWong, RLCChow, WSWoo, YCYuen, MAMTan, KCBSham, PCLam, KSL	2019
	Adipocytes regulate osteogenesis in a novel lipoatrophic mouse model Proceeding/Conference:Hong Kong Medical Journal	Cheong, LYLiu, ZWang, BMa, YXu, A	2020
	Anti-fibrotic Effect of Decorin in Peritoneal Dialysis Proceeding/Conference:Nephrology	Yung, SSYJiang, NChau, KMZhang, QChan, DTM	2020
	Lipopolysaccharide from Gut Microbiota Contributes to Pathogenesis of Murine Lupus Nephritis Proceeding/Conference:JASN Abstract Supplement	Chan, CYCYu, JYung, SSYChan, DTM	2019
	Major Vault Protein Contributes to Tubulo-interstitial Fibrosis in Chronic Kidney Disease Proceeding/Conference:JASN Abstract Supplement	Wong, CYChan, CYCTai, CPYung, SSYChan, DTM	2019
	Acetate from Microbiota Contributes to Pathogenesis of Murine Lupus Nephritis Proceeding/Conference:JASN Abstract Supplement	Yung, SSYYu, JChan, CYCLo, YWong, NLEChan, DTM	2019
	Beliefs, Needs And Information Preference Among Subjects With Obstructive Sleep Apnea In Hong Kong Proceeding/Conference:22nd Diabetes And Cardiovascular Risk Factors – East Meets West Symposium	Lai, YKAChoi, SLChu, PYSin, LYLam, PLIp, MSM	2020